Dual CAR T cells selectively target HER2-expressing tumor cells with HLA loss of heterozygosity

dual-cart-bg

Weist RM, et al. Poster presentation at the Annual Meeting of the American Association for Cancer Research (AACR). April 2022

You are about to leave Immpact Bio's website to an external website.

Immpact Bio is not responsible for the accuracy or content of information contained on external/third-party websites.

You are about to leave Immpact Bio's website to an external website.

Immpact Bio is not responsible for the accuracy or content of information contained on external/third-party websites.

You are about to leave Immpact Bio's website to an external website.

Immpact Bio is not responsible for the accuracy or content of information contained on external/third-party websites.

You are about to leave Immpact Bio's website to an external website.

Immpact Bio is not responsible for the accuracy or content of information contained on external/third-party websites.

ImmPACT Bio is now part of Lyell Immunopharma

If you have a question about a clinical trial, please contact us at info@immpact-bio.com